Navigation Links
New Approach to Treating Precancerous Esophagus Condition

The use of concentrated radio waves appears to be a safe and effective way to "burn" away abnormal cell growth in the esophagus that can be a precursor of cancer .

The new procedure is being tested in patients with Barrett's esophagus, a condition associated with the continued reflux of stomach acids into the lower esophagus that can damage its lining over time. While this condition is relatively common, a small percentage of patients will go on to develop abnormal cell growth known as dysplasia, a condition that can lead to esophageal cancer.

Gastroenterologists at Duke University Medical Center found that delivering concentrated radio waves through a catheter inserted down the esophagus can effectively treat the dysplasia with fewer side effects than current treatment methods. After the treatment, known as radiofrequency ablation, the treated cells die, slough off and are replaced within four to six weeks by new, healthier cells.

In a review of the first 12 patients treated with radiofrequency ablation at Duke, gastroenterologist Darren Pavey, M.B.B.S., found that three months after treatment, 89 percent of patients had more normal-looking esophageal tissue when viewed with an endoscope inserted down the esophagus. When samples of the new cells were analyzed in the laboratory, half of the patients were shown to have healthier tissues.

Pavey presented the results of the analysis on Tuesday, May 22, at the annual Digestive Disease Week conference in Washington, D.C. His analysis was supported by Duke's Division of Gastroenterology.

"In the procedure, which takes about 20 to 30 minutes, we insert a catheter down the esophagus and superficially burn the layer of cells that are abnormal," Pavey said. "The procedure is performed on patients as an outpatient procedure under conscious sedation, much as during a colonoscopy. The patients find that they have little or no discomfort following the procedure
'"/>




Page: 1 2 3

Related medicine news :

1. New Dietary Approach To Manage Kidney Stones
2. Approaching through Telemedicine benefits patients
3. Gel Offers A More Targeted Approach
4. New Cost Effective Approach To Promote Sun Protection
5. Treatment Of Brain Aneurysms By A New Non-Surgical Approach
6. A New Approach In Treatment Neurogenic Detrusor Overactivity In Children
7. A New Diagnostic Approach To Pediatric Interstitial Lung Disease
8. Lazy Eye Can Be Effectively Treated By New Approach
9. Novel Approach to Identify Protein Links with Genetic Disorder
10. NHS To Be Reformed By Using A Hybrid Approach
11. Two-In One Approach To Prevent Incontinence After Prolapse Surgery
Post Your Comments:
(Date:11/21/2008)... 21 NursingCenter.com, the premier... peer reviewed content, has been,updated to impro...stered,users. Powered by Lippincott Williams &...ver 900 peer-reviewed continuing education activit...than 50 leading nursing journals.,Lippincott Will...
(Date:11/21/2008)...v. 21 Barr Pharmaceutica...hareholders overwhelmingly approved the proposals ...arr by Teva Pharmaceuticals Industries Ltd. (Nasda...d the overwhelming support of the transaction by t...s Chairman and CEO. "We are pleased with the progr...
(Date:11/21/2008)... /PRNewswire/ -- For the second year in a row an...Healthcare Worldwide,s agency network won more cre...22nd annual international RX Club Show. , , ...won a total of 59 RX Club Awards of Excellence, in...Healthcare Worldwide agencies include Caudex Medic...
(Date:11/21/2008)...anama - The University of Texas M. D. Anderson Can... effort to eradicate breast cancer in Panama throu... Research of the Americas today at an event with L...d Vivian Fernndez de Torrijos, the First Lady of P...ive are the U.S. Department of State and Susan G. ...
Breaking Medicine News(10 mins):Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2
...to soar in many countries of sub-Saharan Africa, d...the AIDS pandemic. //Out of the 5 million new HIV/...rly 3.2 million cases were in sub-Saharan Africa. ...obal incidence of HIV/AIDS. The high incidence of...
... audience world over it is the turn of super foods...trients are ruling the roost these days.// Tesco h...f Lycopene. The catch is that they are a little ex...t for around Euro 3 for four or five. Likewise the...
...ter are wrong. In fact, they are at increased risk...// Researchers from Britain's Mental Health Found...ed that many adults used alcohol to deal with feel... depression, reported the online edition of the Da...
...lderly patients who are depressed and diabetic may...s, till such time they come out of their depressio... excluded from such intervention modules. Infact, ...g connection between depression in elderly patient...
Other Medicine News:Health News:Soaring Rates Of HIV Infection In Swaziland 2Health News:Superfoods make super healthy humans?? 2
(Date:11/21/2008)... Holdings, Inc. today announced that it has been n... Technology Council (NJTC), a 1,200-member non-pro...etworking opportunities, information and advocacy ... earned the award based on criteria including mark.... , , "We are delighted that the New Jersey...
(Date:11/20/2008)... GlaxoSmithKline (NYSE: ... and Drug Administration (FDA) granted accelerated...eatment of thrombocytopenia in patients with chron...TP) who have had an insufficient response to corti...proval is a significant milestone for PROMACTA and...
(Date:11/20/2008)...Call/ -- Bionovo, Inc.,(Nasdaq: BNVI ) announce...1B,clinical trial of their lead drug candidate fo...he Society for Integrative Oncology,s Fifth Intern...any,s oral presentation was selected,as a top sco...he Best of the,SIO Session on November 20, 2008. ...
(Date:11/20/2008)...EXEL International Corporation (Nasdaq: PRXL ), ...er, today announced that it has opened an office i...clinical research capabilities. With the addition ...ughout five important biopharmaceutical centers in...il, Chile, and Mexico. This expansion further stre...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Aircraft Medical 3A European Patent Hearing 9942 1Aircraft Medical 3A European Patent Hearing 9942 2Dr Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery 1244 1Dr Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery 1244 2DHS Begins Collecting 10 Fingerprints From International Visitors at Boston Logan International Airport 1987 1DHS Begins Collecting 10 Fingerprints From International Visitors at Boston Logan International Airport 1987 2Ohio Prematurity Caucus Forming to Meet Challenge 9938 1Ohio Prematurity Caucus Forming to Meet Challenge 9938 2Ohio Prematurity Caucus Forming to Meet Challenge 9938 3
...ontributing Editor , ,Appendicitis is a co... of individuals sometime in their lives. The cond...ntestine at the proximal colon, becomes obstructed...ensues, which can rapidly evolve to perforation an...y elevated for children and those over 50, rises a...
... Human papillomaviruses (HPVs) are small, closed c...sified by nucleic acid sequence homology rather th...t prevalent sexually transmitted pathogens. Of th...mited number of high and intermediate risk types d...rldwide, HPV has been associated with 99.7% of squ...
Other Medicine Technology:Appendicitis: Evolving Tools to Diagnose a Classic Disease 2Appendicitis: Evolving Tools to Diagnose a Classic Disease 3Testing for Human Papillomavirus 2Testing for Human Papillomavirus 3
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: